From: To: Subject: Attachments: PFAS WG Webex 20th April PFAS WG webex 20 Aord 21 Final Aaencia.docx ill webex user guide en.Ddf Dear Colleagues, I would like to share with you the updated information for our next webex session: *Final Agenda *Instructions for joining a webex (in case of new users) Details for joining the webex (below) Webex Details: Please for MS colleagues kindly log in, indicating your full name, followed by the MS you represent (work for).

dd Jan 21 WP Responsible WP0 DE/NL WP1 DE/NL Activities Coordination Preparation of Call for Evidence (including questionnaire and information document) in agreement between MS Call for Evidence (all MS and ECHA with news alerts and websites of all MS with Link to Helpdesk webpage) Preparation of Restriction option analysis document (all MS) WP2 NL RIME+ Dortmund 1st draft of restriction option analysis document (all MS) 2nd draft of restriction option analysis document (all MS) Finalisation of document, i.e. clarification of restriction options and scope (all MS) Restriction option analysis document to be uploaded on CIRCA (DE/ NL CA) RMOA-Conclusion, PACT-Update Drafting discussion paper Wordt vragenlijst + aanvulling 1e discussion paper Verwerken commentaren van NO, SE, DE, I&W en RIVM deskundige Topic 0 Topic 1 Topic 2 Topic 3 Topic 4 Regular activities Refine PFAS scope based on pragmatic aspects (a.o. coverage of PFAS subgroups by other legislations) Refine PFAS scope based on PFAS degradation patterns and hazard/risk profiles Refine PFAS scope definition based on essential uses Final Regulatory PFAS scope definition and support writing process WP3 DE/DK WP3 Env Coordination and alignment Environmental hazard assessment (different approach from draft content plan) and splitting into pre-assessment and assessment phase is not longer warranted) Identification degradation and biotransfirmation pathways (e.g.

This message may contain information that is not intended for you.

CHAIN OF CUSTODY / ANALYSIS REQUEST FORM Tuscaloosa Testing Laboratory T: 256-353-2910 PAGE 1 of 6 PROJECT INFORMATION Client: Weston Solutions, Inc. 1400 Weston Way, Bldg. 5-2 West Chester, PA 19380 T: 610-701-3761 F: 610-701-7401 Project Manager: Jai Kesari email: i.kesari(westonsolutions.com Project Name: Reference No: Decatur, AL FS IA GP Investigation 02181-129-081-0001 ANALYSES REQUESTED Sampler: T.

CHAIN OF CUSTODY / ANALYSIS REQUEST FORM Tuscaloosa Testing Laboratory T: 256-353-2910 PAGE PROJECT INFORMATION Client: Weston Solutions, Inc. 1400 Weston Way, Bldg. 5-2 West Chester, PA 19380 T: 610-701-3761 F: 610-701-7401 Project Manager: Jai Kesari em<ail: i.kesari(5)westonsolutions.com Project Name: Reference No: Decatur, AL FSIA GP Investigation 02181-129-081-0001 1 \NALYSES REQUESTEI Sampler: T.

Phone Conversation Report f erni 0 / r wCOPi 3M 2?

Study Title Solubility of Perfluoro-1-octanesulfonyl Fluoride (P O S F) in W ater Data Requirement 40 CFR 160.105(b) Author Mark E.

/|R 1%-OS07 ACUTE TOXICITY TO AQUATIC INVERTABRATES (DAPHNIA MAGNA) TEST SUBSTANCE Identity: Perfluorooctanoic acid, ammonium salt; may also be referred to as PFOA ammonium salt, Ammonium perfluorooctanoate, PFO, FC- 116, FC-126, FC-169, or FC-143.

\Sl1& FINAL REPORT r-o 3 TJ TJ O 30 tin i to * r --*d} TJ 3: -`- c `r j r r i O C3 ro fs> O Bioconcentration test o f 2-perfluoroalkyl (C=4-16) ethanol [This test was performed using 2-{perfluorooctyl) ethanol (Test substance number K-1518)] in carp (Test number : 51518) Kurume Laboratory Chemicals Evaluation and Research Institute, Japan 000001*1 STATEMENT 51518 Kumme Laboratory Chemicals Evaluation and Research Institute, Japan Sponsor ASAHI GLASS Co., Ltd.

*R a 6 _ PERSONAL AND CONFIDENTIAL CC: J .

AA A 6 - ih0 TSCA NCIC Notification Form for CBI Documents Docket Number: ________________ Document Control Number: 7Document Date: ~ 63^3 o o q 5 S' ______________________________________ Document Type: F __________________ o- opmoNCu=O>> < r> "90 XT -- T *> o0 ron O cn ro O(TTChSFBeCTIdA)Sou,CAcnANudRDmeEreIQTnSUIteMIrcRPetEOfiSoSeEEnrSPe1nCA4cRoTIeMOfdINPtahRAbLOeoPTTvEEoeCNxiATsicLFcTRSlIOEauSMibmFsPeOtUdaRBnaLTscIHCecEsDoKICSnNCofOiLndWOteISNrnUoGtRilaAEAlNScDbCutWBs(ITiILnSLOeFCBsUTAsLA)iIUn.NNfEToADhUrUaTmHNtaODsteERiocRIZntEioDn RELEASE ORDISCLOSURE OFSUCHINFORMATION.

Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats Page 1 of 12 Appendix G: Amendments and Deviations (Copies) Fraunhofer ITEM Final Report 01 G 00 0 02 [Appendices G] 28 Day Repeated Dermal Contact Study of 3M Test Articles in Sprague-Dawley Rats Page 2 of 12 Study Plan Deviation Study No.: 01 G 00 0 02 Date: 8.5.00 Deviation No.: 1 S ubject: Fabric conditioning Page: 8 Paragraph: 5,3.2 Change: In addition to the description in the study plan (paragraph 5.3.2, page 8) the fabrics were pre-conditioned w ith deionisized w ater (spray application).